| Financial Year |
March 31 2023 |
| Monetary Funds |
7,750,922,783.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
349,515,412.58 |
| Accounts Receivable |
4,990,511,752.78 |
| Advances to Suppliers |
1,791,367,853.12 |
| Other Receivables |
196,260,106.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
430,372.19 |
| Inventories |
3,236,431,480.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
201,720,903.93 |
| Total Current Assets |
20,454,802,214.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,526,983.05 |
| Investment Properties |
142,292,431.46 |
| Fixed Assetes |
3,461,124,899.59 |
| Under-construction Projects |
198,163,654.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,397,258,516.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,619,212.98 |
| Deferred Income Tax Assets |
107,858,069.88 |
| Other Non-Current Assets |
15,310,394.47 |
| Sub-Total of Non-Current Assets |
8,237,351,765.33 |
| Total Assets |
28,692,153,980.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,338,755,231.44 |
| Accounts Payable |
3,857,791,251.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
140,293,404.69 |
| Taxes Payable |
435,952,455.89 |
| Interest Payable |
-- |
| Dividend Payable |
10,622,218.11 |
| Other payables |
314,367,929.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
242,356,950.17 |
| Other Current Liabilities |
326,494,398.62 |
| Sub-Total of Current Liabilities |
11,159,767,182.47 |
| Long-term Loans |
111,435,555.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,936,512,198.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,805,654.14 |
| Deferred Income Tax Liabilities |
110,870,410.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,457,831,852.87 |
| Total Liabilities |
14,617,599,035.34 |
| Paid-In Capital(Or Share Stock) |
7,213,555,890.00 |
| Capital Surplus |
14,803,118,160.15 |
| Surplus Reserve |
118,216,946.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-9,003,640,708.40 |
| Minority Stockholder's Interest |
610,907,556.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,463,647,388.59 |
| Owner's Equity（Stockholder's Equity） |
14,074,554,944.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,692,153,980.19 |
